REQUEST A DEMO
Total
USD $0.00
Search more companies

Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) (Taiwan, China)

Main Activities: Electronic Shopping and Mail-Order Houses | Other Information Services | Internet Publishing and Broadcasting and Web Search Portals | Travel Arrangement and Reservation Services
Full name: Navicare Biotech Co., Ltd. Profile Updated: July 15, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) is an enterprise in Taiwan, China, with the main office in New Taipei City. The enterprise operates in the Electronic Shopping and Mail-Order Houses industry. The company was established on July 12, 2010. 101 - 500 (2025) employees currently work for Navicare Biotech Co., Ltd. (纳维康生技股份有限公司). There was a net sales revenue increase of 14.87% reported in Navicare Biotech Co., Ltd. (纳维康生技股份有限公司)’s latest financial highlights for Q2C2026. Its’ total assets recorded a negative growth of 4.93%. The enterprise’s net profit margin increased by 6.51% in 2026.

Headquarters
Rm. 6, 2F., No. 262, Sec. 2, Beixin Rd., Xindian Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) report to view the information.

Website: http://www.gomaji.com

Basic Information
Total Employees:
Purchase the Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) report to view the information.
Incorporation Date:
July 12, 2010
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
4.32%
Purchase this report to view the information.
3.89%
Purchase this report to view the information.
2.13%
Purchase this report to view the information.
2%
Purchase this report to view the information.
1.93%
Subsidiaries
Majipharmaceutical Croup Pty Ltd (Australia)
100%
一起旅行社股份有限公司
100%
蕾綿國際股份有限公司
100%
Company Performance
Financial values in the chart are available after Navicare Biotech Co., Ltd. (纳维康生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
14.87%▲
Total Operating Revenue
14.39%▲
Operating Profit
69.58%▲
EBITDA
68.09%▲
Net Profit/Loss for the Period
51.86%▲
Total Assets
-4.93%▼
Total Equity
-3.86%▼
Operating Profit Margin
7.08%▲
Net Profit Margin
6.51%▲
Return on Equity (ROE)
4.5%▲
Debt / Equity
-3.27%▼
Quick Ratio
-0.02%▼
Cash Ratio
-0.22%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?